Javascript must be enabled to continue!
802 PERIOPERATIVE AND SHORT-TERM OUTCOMES FOR PRIMARY ANTIREFLUX SURGERY: FUNDOPLICATION VS. RNY RECONSTRUCTION
View through CrossRef
Abstract
Laparoscopic fundoplication is the gold standard for treatment of gastroesophageal reflux disease (GERD); however, RNY reconstruction may be an alternative option in patients with complex pathophysiology and other risk factors. This study aimed to compare perioperative and short-term outcomes between primary fundoplication and RNY reconstruction.
Methods
After IRB approval, a prospectively maintained esophageal surgery database was retrospectively reviewed to identify patients who underwent primary fundoplication or RNY reconstruction from September 2016 to July 2020. We retrieved perioperative outcomes (operative time, length of hospital stay, intraoperative and postoperative complications) along with GERD-Health-Related Quality of Life (HRQL) scores at annual follow-up.
Results
During the study period, 226 patients underwent surgery (fundoplication: 210; RNY: 16). The most common indication for RNY was severe esophageal dysmotility or morbid obesity. There was only one conversion to open surgery due to adhesions (fundoplication group). The operative time, length of hospital stay, and ICU stay were significantly lower in the fundoplication group. Rates of intraoperative (fundoplication: 3% vs RNY: 0) and postoperative complications (Clavien-Dindo ≥II) (fundoplication: 3% vs RNY: 6%) were not significantly different between groups. Both groups had a significant and similar improvement of GERD-HRQL scores 1 year after surgery (Table 1).
Conclusion
Primary antireflux surgery is associated with low perioperative morbidity and excellent short-term outcomes. RNY reconstruction and fundoplication have similar outcomes. More liberal use of RNY reconstruction as the primary antireflux surgery in patients at high risk of failure with fundoplication should be explored.
Oxford University Press (OUP)
Title: 802 PERIOPERATIVE AND SHORT-TERM OUTCOMES FOR PRIMARY ANTIREFLUX SURGERY: FUNDOPLICATION VS. RNY RECONSTRUCTION
Description:
Abstract
Laparoscopic fundoplication is the gold standard for treatment of gastroesophageal reflux disease (GERD); however, RNY reconstruction may be an alternative option in patients with complex pathophysiology and other risk factors.
This study aimed to compare perioperative and short-term outcomes between primary fundoplication and RNY reconstruction.
Methods
After IRB approval, a prospectively maintained esophageal surgery database was retrospectively reviewed to identify patients who underwent primary fundoplication or RNY reconstruction from September 2016 to July 2020.
We retrieved perioperative outcomes (operative time, length of hospital stay, intraoperative and postoperative complications) along with GERD-Health-Related Quality of Life (HRQL) scores at annual follow-up.
Results
During the study period, 226 patients underwent surgery (fundoplication: 210; RNY: 16).
The most common indication for RNY was severe esophageal dysmotility or morbid obesity.
There was only one conversion to open surgery due to adhesions (fundoplication group).
The operative time, length of hospital stay, and ICU stay were significantly lower in the fundoplication group.
Rates of intraoperative (fundoplication: 3% vs RNY: 0) and postoperative complications (Clavien-Dindo ≥II) (fundoplication: 3% vs RNY: 6%) were not significantly different between groups.
Both groups had a significant and similar improvement of GERD-HRQL scores 1 year after surgery (Table 1).
Conclusion
Primary antireflux surgery is associated with low perioperative morbidity and excellent short-term outcomes.
RNY reconstruction and fundoplication have similar outcomes.
More liberal use of RNY reconstruction as the primary antireflux surgery in patients at high risk of failure with fundoplication should be explored.
Related Results
Tailored Antireflux Surgery for Gastroesophageal Reflux Disease: Effectiveness and Risk of Postoperative Dysphagia
Tailored Antireflux Surgery for Gastroesophageal Reflux Disease: Effectiveness and Risk of Postoperative Dysphagia
AbstractThe Nissen fundoplication is not the proper antireflux procedure for patients with poor esophageal peristalsis as it does not strengthen impaired esophageal peristalsis. Th...
806. MINIMALLY INVASIVE REVISION FUNDOPLICATION, IS IT SAFE AND FEASIBLE? SINGLE CENTER EXPERIENCE
806. MINIMALLY INVASIVE REVISION FUNDOPLICATION, IS IT SAFE AND FEASIBLE? SINGLE CENTER EXPERIENCE
Abstract
Introduction
Laparoscopic fundoplication has become standard of care for patients with refractory gastroesophageal refl...
Is It Safe to Combine a Fundoplication to Sleeve Gastrectomy? Review of Literature
Is It Safe to Combine a Fundoplication to Sleeve Gastrectomy? Review of Literature
Background and Objectives: The rising numbers of laparoscopic sleeve gastrectomy (LSG) procedures now being performed worldwide will likely be followed by an increasing number of p...
Lap. Nissen Fundoplication leads to better respiratory Symptom Control than Toupet in the long-term of 20 years
Lap. Nissen Fundoplication leads to better respiratory Symptom Control than Toupet in the long-term of 20 years
Abstract
Introduction:
Since we are performing anti-reflux surgery for thirty years, it was worth re-examining our patients on the long-term to enlarge the body of evidence...
Incidental Cholecystectomy during Laparoscopic Antireflux Surgery
Incidental Cholecystectomy during Laparoscopic Antireflux Surgery
Cholelithiasis and gastroesophageal reflux are both very common diseases that may occur simultaneously. Management of asymptomatic gallstones is still controversial. Because severe...
A Comparative Study between Nissen's Fundoplication with or without Endoscopic Mucosal Resection in the Treatment of Barrett’s Oesophagus: a Meta-Analysis
A Comparative Study between Nissen's Fundoplication with or without Endoscopic Mucosal Resection in the Treatment of Barrett’s Oesophagus: a Meta-Analysis
Abstract
Background
It is already known that Barrett’s esophagus (BE) is a premalignant condition in which the normal squamous e...
Abstract 6268: TT125-802 is a potent and highly selective CBP/p300 bromodomain inhibitor for the treatment of castration resistant prostate cancer and haematological malignancies
Abstract 6268: TT125-802 is a potent and highly selective CBP/p300 bromodomain inhibitor for the treatment of castration resistant prostate cancer and haematological malignancies
Abstract
The paralogous lysine acetyltransferases CREB-binding protein (CBP) and p300 are key epigenetic regulators involved in diverse signaling pathways in cancer....
Impact of symptom–reflux association analysis on long-term outcome after Nissen fundoplication
Impact of symptom–reflux association analysis on long-term outcome after Nissen fundoplication
Abstract
Background
A positive symptom association probability (SAP) is regarded as an important selection criterion for antiref...

